Abstract
Purpose
Prolonged duration of intrapartum oxytocin exposure is included as a risk factor within widely adopted obstetric hemorrhage risk stratification tools. However, the duration of exposure that confers increased risk is poorly understood. This study aimed to assess the association between duration of intrapartum oxytocin exposure and obstetric blood loss, as measured by quantitative blood loss, and hemorrhage-related maternal morbidity.
Methods
This was a retrospective cohort study of all deliveries from 2018 to 2019 at a single medical center. We included patients who had received any intrapartum oxytocin, and we categorized them into 1 of 5 groups: > 0–2, ≥ 2–4, ≥ 4–6, ≥ 6–12, and ≥ 12 h of intrapartum oxytocin exposure. The primary outcomes were mean quantitative blood loss, proportion with obstetric hemorrhage (defined as quantitative blood loss ≥ 1000 mL), and proportion with obstetric hemorrhage-related morbidity, a composite of hemorrhage-related morbidity outcomes. Secondary outcomes were hemorrhage-related pharmacologic and procedural interventions. A stratified analysis was also conducted to examine primary and secondary outcomes by delivery mode.
Results
Of 5332 deliveries between January 1, 2018 and December 31, 2019 at our institution, 2232 (41.9%) utilized oxytocin for induction or augmentation. 326 (14.6%) had exposure of > 0–2 h, 295 (13.2%) ≥ 2–4 h, 298 (13.4%) ≥ 4–6 h, 562 (25.2%) ≥ 6–12 h, and 751 (33.6%) ≥ 12 h. Across all deliveries, there was higher mean quantitative blood loss (p < 0.01) as well as increased odds of obstetric hemorrhage (adjusted odds ratio [aOR] 1.52, 95% confidence interval [CI] 1.21–1.91) for those with ≥ 12 h of oxytocin compared to all groups between > 0-12 h of exposure. In our stratified analysis, ≥ 12 h of oxytocin exposure was associated with higher mean quantitative blood loss (p = 0.04) and odds of obstetric hemorrhage in vaginal deliveries (aOR 1.47, 95% CI: 1.03–2.11), though not in cesarean deliveries (aOR 1.16, 95% CI 0.82–1.62). There were no differences in proportion with obstetric hemorrhage-related morbidity across all deliveries (p = 0.40) or in the stratified analysis.
Conclusion
Intrapartum oxytocin exposure of ≥ 12 h was associated with increased quantitative blood loss and odds of obstetric hemorrhage in vaginal, but not cesarean, deliveries.
Similar content being viewed by others
Data availability
Data available on request from the authors.
References
Geller SE, Adams MG, Kelly PJ, Kodkany BS, Derman RJ (2006) Postpartum hemorrhage in resource-poor settings. Int J Gynecol Obstet 92(3):202–211. https://doi.org/10.1016/j.ijgo.2005.12.009
Petersen EE, Davis NL, Goodman D et al (2021) Vital signs: pregnancy-related deaths, United States, 2011–2015, and Strategies for Prevention, 13 States, 2013–2017. https://www.cdc.gov/mmwr. Accessed 17 Apr 2021
Creanga AA, Syverson C, Seed K, Callaghan WM, Author OG (2017) Pregnancy-related mortality in the United States, 2011–2013 HHS public access author manuscript. Obstet Gynecol 130(2):366–373. https://doi.org/10.1097/AOG.0000000000002114
Bateman BT, Berman MF, Riley LE, Leffert LR (2010) The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Soc Obstet Anesth Perinatol 110(5):1368–1373. https://doi.org/10.1213/ANE.0b013e3181d74898
Mehrabadi A, Hutcheon JA, Lee L, Kramer MS, Liston RM, Joseph KS (2013) Epidemiological investigation of a temporal increase in atonic postpartum haemorrhage: a population-based retrospective cohort study. BJOG. https://doi.org/10.1111/1471-0528.12149
Balki M, Erik-Soussi M, Kingdom J, Carvalho JCA (2013) Oxytocin pretreatment attenuates oxytocin-induced contractions in human myometrium in vitro. Anesthesiology 119(3):552–561. https://doi.org/10.1097/ALN.0B013E318297D347
Robinson C, Schumann R, Zhang P, Young RC, Charleston P (2003) Oxytocin-induced desensitization of the oxytocin receptor. Am J Obstet Gynecol. https://doi.org/10.1067/mob.2003.22
Gabel K, Lyndon A, Main E (2015) CMQCC obstetric hemorrhage toolkit: risk factor assessment. https://www.cmqcc.org/content/risk-factor-assessment. Accessed 20 Apr 2021
Committee on Practice Bulletins-Obstetrics (2017) Practice bulletin no. 183: postpartum hemorrhage. Obstet Gynecol 130(4):e168–e186. https://doi.org/10.1097/AOG.0000000000002351
Khireddine I, le Ray C, Dupont C, Rudigoz RC, Lè Ne Bouvier-Colle MH, Deneux-Tharaux C (2013) Induction of labor and risk of postpartum hemorrhage in low risk parturients. PLoS ONE 8(1):E54858. https://doi.org/10.1371/journal.pone.0054858
Ekin A, Gezer C, Solmaz U, Taner CE, Dogan A, Ozeren M (2015) Predictors of severity in primary postpartum hemorrhage. Arch Gynecol Obstet 292:1247–1254. https://doi.org/10.1007/s00404-015-3771-5
Tran G, Kanczuk M, Balki M (2017) The association between the time from oxytocin cessation during labour to Cesarean delivery and postpartum blood loss: a retrospective cohort study. Can J Anesth 64(8):820–827. https://doi.org/10.1007/s12630-017-0874-4
Sheiner E, Sarid L, Levy A, Seidman DS, Hallak M (2005) Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: a population-based study. J Mater-Fetal Neonatal Med 18(3):149–154. https://doi.org/10.1080/14767050500170088
Grotegut CA, Paglia MJ, Johnson LN, Thames B, James AH (2011) Oxytocin exposure in women with postpartum hemorrhage secondary to uterine atony. Am J Obstet Gynecol 204(1):56.e1-56.e6. https://doi.org/10.1016/j.ajog.2010.08.023
Belghiti J, Kayem G, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C (2011) Oxytocin during labour and risk of severe postpartum haemorrhage: a population-based, cohort-nested case control study. BMJ Open. https://doi.org/10.1136/bmjopen-2011-000514
Wetta LA, Szychowski JM, Seals S, Mancuso MS, Biggio JR, Tita AT (2013) Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery. Am J Obstet Gynecol 209(1):51.e1-51.e6. https://doi.org/10.1016/j.ajog.2013.03.011
Sosa CG, Althabe F, Belizán JM, Buekens P (2009) Risk factors for postpartum hemorrhage in vaginal deliveries in a Latin-American population. Obstet Gynecol 113(6):1313–1319. https://doi.org/10.1097/AOG.0b013e3181a66b05
Foley A, Gunter A, Nunes KJ, Shahul S, Scavone BM (2018) Patients undergoing cesarean delivery after exposure to oxytocin during labor require higher postpartum oxytocin doses. Anesth Analg 126(3):920–924. https://doi.org/10.1213/ANE.0000000000002401
Driessen M, Bouvier-Colle MH, Dupont C, Khoshnood B, Rudigoz RC, Deneux-Tharaux C (2011) Postpartum hemorrhage resulting from uterine atony after vaginal delivery: factors associated with severity. Obstet Gynecol 117(1):21–31. https://doi.org/10.1097/AOG.0b013e318202c845
Ende HB, Lozada MJ, Chestnut DH et al (2021) Risk factors for atonic postpartum hemorrhage. Obstet Gynecol 137(2):305–323. https://doi.org/10.1097/AOG.0000000000004228
Birth Sisters (2021) Boston Medical Center. https://www.bmc.org/obstetrics/birth-sisters. Accessed 07 Dec 2021
Lyndon A, McNulty J, VAnderWal B, Gabel K, Huwe V, Main E (2015) Cumulative quantitative assessment of blood loss. CMQCC obstetric hemorrhage toolkit version 2.0. Calif Mater Qual Care Collab
IBM Corp (2020) Released 2020. IBM SPSS statistics for windows, version 27.0. IBM Corp
Erickson EN, Carlson NS (2020) Predicting postpartum hemorrhage after low-risk vaginal birth by labor characteristics and oxytocin administration. J Obstet Gynecol Neonatal Nurs 49(6):549–563. https://doi.org/10.1016/j.jogn.2020.08.005
Committee on Practice Bulletins-Obstetrics (2009) Practice Bulletin No. 107: Induction of Labor. Obstet Gynecol 114(2 Pt 1):386–397. https://doi.org/10.1097/AOG.0b013e3181b48ef5
Lertbunnaphong T, Lapthanapat N, Leetheeragul J, Hakularb P, Ownon A (2016) Postpartum blood loss: visual estimation versus objective quantification with a novel birthing drape. Singap Med J 57(6):325–328. https://doi.org/10.11622/smedj.2016107
Razvi K, Chua S, Arulkumaran S, Ratnam SS (1996) A comparison between visual estimation and laboratory detennination of blood loss during the third stage of labour. Aust N Z J Obstet Gynaecol 36(2):152–154. https://doi.org/10.1111/J.1479-828X.1996.TB03273.X
(2019) Quantitative blood loss in obstetric hemorrhage: ACOG committee opinion summary, number 794. Obstet Gynecol 134(6):1368-1369. https://doi.org/10.1097/AOG.0000000000003565
Hancock A, Weeks AD, Lavender DT (2015) Is accurate and reliable blood loss estimation the “crucial step” in early detection of postpartum haemorrhage: an integrative review of the literature. BMC Pregnancy Childbirth. https://doi.org/10.1186/S12884-015-0653-6
Prasertcharoensuk W, Swadpanich U, Lumbiganon P (2000) Accuracy of the blood loss estimation in the third stage of labor. Int J Gynecol Obstet 71(1):69–70. https://doi.org/10.1016/S0020-7292(00)00294-0
Toledo P, McCarthy RJ, Hewlett BJ, Fitzgerald PC, Wong CA (2007) The accuracy of blood loss estimation after simulated vaginal delivery. Anesth Analg 105(6):1736–1740. https://doi.org/10.1213/01.ANE.0000286233.48111.D8
Funding
The authors have not disclosed any funding.
Author information
Authors and Affiliations
Contributions
MA: conceptualization, methodology, validation, formal analysis, investigation, writing—original draft, and visualization. MW: conceptualization, methodology, validation, investigation, data curation, writing—review and editing, and project administration. AS: investigation, and writing—review and editing. ST: investigation, and writing—review and editing. DA: investigation, and writing—review and editing. SY: investigation, and writing—review and editing. LC: investigation, and writing—review and editing. CY: conceptualization, methodology, and writing—review and editing. AC: conceptualization, methodology, writing—review and editing, and supervision.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that no funds, grants, or other supports were received during the preparation of this manuscript. The authors have no relevant financial or non-financial interests to disclose.
Ethical approval
This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Approval was granted by the Boston Medical Center/Boston University Medical Campus Institutional Review Board (IRB H-39914).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendices
Appendix 1
Boston Medical Center Obstetric Hemorrhage Bundle Components
Readiness |
System level readiness |
Hemorrhage carts are available on labor and delivery floor and operating rooms, triage and postpartum floors, with massive transfusion supplies, hemorrhage response checklist, intrauterine balloons, and compressions stitches |
Hemorrhage medications are available in labor and delivery floor and operating rooms, triage and postpartum floors medication dispenser (Pyxis) |
Emergency response team: back-up obstetric MD attending and 24/7 on-call back-up advanced gynecologic surgical specialist who can be called in for complex cases, 24/7 on-call interventional radiology |
Transfusion: massive transfusion protocol and emergency release transfusion protocols |
Unit education on protocols for all team members (RN, OB MD, FM MD, Anesthesia MD, CNM, residents) |
Anesthesia: all patients receive an anesthesia consult on admission to labor and delivery and are thereby screened for hemorrhage risk factors as a part of that admission work-up |
Recognition and prevention |
Definition, early recognition and triggers |
Definition of hemorrhage as quantitative blood loss > 1000 mL |
Early recognition: regular interval assessment during delivery and postpartum of QBL |
Intraoperative antibiotics redosing after > 1500 mL QBL |
Tranexamic acid: consider giving after > 1000-1500 mL QBL |
Risk assessment (see Appendix 2) |
Assessment of hemorrhage risk: a specific form is used on admission, every 12 h of delivery care, and on transfer to postpartum to assess an individual patient’s risk of obstetric hemorrhage |
Universal screening: all patients admitted get a blood type and screen drawn. If the patient is considered high risk via the risk assessment tool, a crossmatch is ordered as well |
Cumulative quantitative blood loss |
Vaginal deliveries: Under-buttocks drape with clear conical pouch with QBL measurements in 50 mL increments printed on the outside of the drape for easy visual quantification. Quantification initiated following delivery (prior to placental delivery). Blood soaked items weighed and blood volume calculated by subtracting weight of wet from dry (with 1 g additional weight equivalent to 1 mL blood loss). Add calculated blood volume from weighted soaked item and drape volume |
Cesarean deliveries: Suction device, graduated cylinders and drapes utilized, all blood-soaked materials weighed and irrigation/amniotic sac rupture accounted for. Quantification starts after amniotic sac rupture or after delivery. Frequent intake and output measurements verbally shared with all team members throughout the case. Cumulative volume calculated from weighted soaked items and blood in suction cannister |
Active management of third stage of labor |
Prophylactic oxytocin administration immediately after delivery of infant |
Uterine massage immediately after delivery of infant |
Umbilical cord traction for placental delivery |
Response |
Emergency management plan |
Staged response to blood loss: checklist and poster posted in every L&D room, on labor and delivery, inside of the operating room, and on the hemorrhage carts that includes medications to give at specific QBL cutoffs, pagers, or numbers to contact for emergency |
Reporting/systems |
Perinatal quality improvement/safety |
Perinatal safety specialist instills and promotes culture of team huddles for high-risk patients and systematically debriefing after all clinically significant events to identify successes and opportunities |
Hemorrhage data are collected and analyzed on a regular basis. Safety specialist investigates all hemorrhages (all deliveries with QBL > 1000 cc) |
Quality improvement team helps to find barriers to implementation and make system-level adjustments to improve the implementation of this new protocol |
Appendix 2
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Alexander, M.V., Wang, M.J., Srivastava, A. et al. Association between duration of intrapartum oxytocin exposure and obstetric hemorrhage. Arch Gynecol Obstet 309, 491–501 (2024). https://doi.org/10.1007/s00404-022-06901-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-022-06901-w